203 related articles for article (PubMed ID: 16219821)
21. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?
Bisdas S; Kirkpatrick M; Giglio P; Welsh C; Spampinato MV; Rumboldt Z
AJNR Am J Neuroradiol; 2009 Apr; 30(4):681-8. PubMed ID: 19179427
[TBL] [Abstract][Full Text] [Related]
22. Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes.
Mangla R; Ginat DT; Kamalian S; Milano MT; Korones DN; Walter KA; Ekholm S
J Neurooncol; 2014 Jan; 116(2):325-31. PubMed ID: 24178441
[TBL] [Abstract][Full Text] [Related]
23. Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading.
Server A; Graff BA; Orheim TE; Schellhorn T; Josefsen R; Gadmar ØB; Nakstad PH
Neuroradiology; 2011 Jun; 53(6):435-47. PubMed ID: 20857284
[TBL] [Abstract][Full Text] [Related]
24. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.
Fuss M; Wenz F; Scholdei R; Essig M; Debus J; Knopp MV; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):53-8. PubMed ID: 10924971
[TBL] [Abstract][Full Text] [Related]
25. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
26. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.
Emblem KE; Scheie D; Due-Tonnessen P; Nedregaard B; Nome T; Hald JK; Beiske K; Meling TR; Bjornerud A
AJNR Am J Neuroradiol; 2008 Oct; 29(9):1664-70. PubMed ID: 18583405
[TBL] [Abstract][Full Text] [Related]
27. Semi-automated and automated glioma grading using dynamic susceptibility-weighted contrast-enhanced perfusion MRI relative cerebral blood volume measurements.
Friedman SN; Bambrough PJ; Kotsarini C; Khandanpour N; Hoggard N
Br J Radiol; 2012 Dec; 85(1020):e1204-11. PubMed ID: 23175486
[TBL] [Abstract][Full Text] [Related]
28. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
[TBL] [Abstract][Full Text] [Related]
29. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
[TBL] [Abstract][Full Text] [Related]
31. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
Gahramanov S; Muldoon LL; Li X; Neuwelt EA
Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging.
Preul C; Kühn B; Lang EW; Mehdorn HM; Heller M; Link J
Eur J Radiol; 2003 Dec; 48(3):244-51. PubMed ID: 14652141
[TBL] [Abstract][Full Text] [Related]
35. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
[TBL] [Abstract][Full Text] [Related]
36. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
37. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
[TBL] [Abstract][Full Text] [Related]
38. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.
Awasthi R; Rathore RK; Soni P; Sahoo P; Awasthi A; Husain N; Behari S; Singh RK; Pandey CM; Gupta RK
Neuroradiology; 2012 Mar; 54(3):205-13. PubMed ID: 21541688
[TBL] [Abstract][Full Text] [Related]
39. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
40. Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors.
Spampinato MV; Wooten C; Dorlon M; Besenski N; Rumboldt Z
Neuroradiology; 2006 Dec; 48(12):867-74. PubMed ID: 17013587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
